FDA
approval
· 2025-05-12
FDA Approved: EVOTAZ — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
Summary
FDA approved a supplemental application for EVOTAZ (atazanavir and cobicistat) from E.R. Squibb & Sons, L.L.C., indicating a modification to the product labelin…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for EVOTAZ (ATAZANAVIR AND COBICISTAT)